Elotuzumab (anti-SLAMF7)

Catalog No.A2034 Synonyms: BMS-901608, PDL063, HuLuc63

For research use only.
Not for use in humans.

Elotuzumab (anti-SLAMF7, BMS-901608, PDL063, HuLuc63) is a humanized monoclonal antibody that binds human signaling lymphocytic activation molecule F7 (hSLAMF7, also known as CS1, CD319, or CRACC). Elotuzumab shows a dual mechanism of action that includes the direct activation of natural killer (NK) cells and the induction of NK cell–mediated antibody-dependent cellular cytotoxicity.

Elotuzumab (anti-SLAMF7)

Purity & Quality Control

Choose Selective CD markers Inhibitors

Biological Activity

Description Elotuzumab (anti-SLAMF7, BMS-901608, PDL063, HuLuc63) is a humanized monoclonal antibody that binds human signaling lymphocytic activation molecule F7 (hSLAMF7, also known as CS1, CD319, or CRACC). Elotuzumab shows a dual mechanism of action that includes the direct activation of natural killer (NK) cells and the induction of NK cell–mediated antibody-dependent cellular cytotoxicity.

Protocol (from reference)

Product Details

CAS No. 915296-00-3
Molecular Weight 145 kD
Formulation PBS Buffer, PH 7.4
Isotype Human IgG1, κ
Source CHO cells
Storage Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Sterility 0.2 μM filtered

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Elotuzumab (anti-SLAMF7) | Elotuzumab (anti-SLAMF7) supplier | purchase Elotuzumab (anti-SLAMF7) | Elotuzumab (anti-SLAMF7) cost | Elotuzumab (anti-SLAMF7) manufacturer | order Elotuzumab (anti-SLAMF7) | Elotuzumab (anti-SLAMF7) distributor